{"disease":{"id":"pdac-pancreatic-ductal-adenocarcinoma","name":"pdac pancreatic ductal adenocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07117045","title":"Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":400000,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT07243262","title":"Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)","phase":"","overall_status":"RECRUITING","enrollment_count":6079,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT06122896","title":"Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT06151223","title":"A Prospective Registry for Patients at High-Risk for Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05845801","title":"Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT06445062","title":"Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":1130,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT06947382","title":"Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1066,"lead_sponsor_name":"Immunovia, Inc.","has_results":false},{"nct_id":"NCT07252232","title":"Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT07262957","title":"Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT07224802","title":"Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting","phase":"","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT07104864","title":"Early Detection of PDAC in Patients With Chronic Pancreatitis","phase":"","overall_status":"COMPLETED","enrollment_count":359,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT07500259","title":"Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":188,"lead_sponsor_name":"Luxembourg Institute of Health","has_results":false},{"nct_id":"NCT05853198","title":"Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability","phase":"NA","overall_status":"RECRUITING","enrollment_count":165,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT05669287","title":"Defining a Vascular Phenotype of Pancreatic Ductal Adenocarcinoma With CT Perfusion Using Quantitative Radiomics","phase":"NA","overall_status":"UNKNOWN","enrollment_count":125,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT07444840","title":"How Does Pre-operative Biliary Drainage in Pancreatic Adenocarcinoma Affect Surgical Outcomes in Pancreatic Cancer Surgery","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"East Lancashire Hospitals NHS Trust","has_results":false},{"nct_id":"NCT05355298","title":"ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":62,"lead_sponsor_name":"Amplia Therapeutics Limited","has_results":false},{"nct_id":"NCT05262855","title":"Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"SOFIE","has_results":false},{"nct_id":"NCT03767582","title":"Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT05947825","title":"Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT03727880","title":"Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Lei Zheng","has_results":true},{"nct_id":"NCT05642962","title":"Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":17,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT07399015","title":"Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Endevica Bio","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}